Date & Time
Tuesday, October 3, 2023, 4:30 PM - 5:30 PM
457 Evaluating High-Cost Therapies for Diabetic Patients

This presentation will identify special populations at elevated risk of type 2 diabetes sequelae: chronic kidney disease, heart failure, cardiovascular disease, common hypoglycemia, and obesity. With the anti-diabetic drug market expanding to capture relevant indications, this presentation will not only identify those at high risk, but also provide direction for providers to pinpoint those special populations and decide whether it is appropriate to continue high-cost therapies.

Educational Objectives
  • Identify comorbid conditions or disease states associated with type 2 diabetes
  • Construct pharmacologic treatment plans using relevant patient data
  • Analyze the effectiveness of an educational-driven or process-driven prescribing practice regarding antidiabetic agents

Level: Intermediate